Home › NDC Lookup › RxCUI directory › RxCUI 1736048

Levetiracetam 500 MG Tablet for Oral Suspension — RxCUI 1736048

Name: Levetiracetam 500 MG Tablet for Oral Suspension (RxCUI 1736048)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1736048 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1736048

Official nameLevetiracetam 500 MG Tablet for Oral Suspension

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped6

Package NDCs mapped9

Reported Medicaid activity (SDUD)602 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levetiracetam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Levetiracetam is an anti-seizure medicine. Depending on the product and your age, it can be used to treat partial-onset seizures (seizures starting in one part of the brain), myocl...
What is levetiracetam actually used for?
It can, especially when you first start taking it. Drowsiness, fatigue, and dizziness are among the most common side effects and tend to be most noticeable in the first few weeks....
Will levetiracetam make me feel tired or foggy?

📖 Read our full Levetiracetam guide →

🕸️ Concept Web — How Levetiracetam 500 MG Tablet for Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Levetiracetam 500 MG Tablet for Oral Suspension RxCUI 1736048 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Levetiracetam 114477 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Spritam 1736038 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Levetiracetam Tablet for Oral Suspension 1869554 SCDF
- Levetiracetam Oral Liquid Product 1163450 SCDG
- Levetiracetam Oral Product 1163451 SCDG
- Levetiracetam Tablet for Oral Suspension [Spritam] 1869556 SBDF
- Spritam Oral Liquid Product 1869557 SBDG
- Spritam Oral Product 1736042 SBDG
- Tablet for Oral Suspension 1861409 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Levetiracetam 500 MG 330370 SCDC
- Levetiracetam 500 MG Tablet for Oral Suspension [Spritam] 1736050 SBD
- Levetiracetam 500 MG [Spritam] 1736049 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Levetiracetam 500 MG SCDC · 330370
Levetiracetam Tablet for Oral Suspension SCDF · 1869554
Levetiracetam Oral Liquid Product SCDG · 1163450
Levetiracetam Oral Product SCDG · 1163451

Brand-Name Concepts

Levetiracetam 500 MG Tablet for Oral Suspension [Spritam] SBD · 1736050
Levetiracetam 500 MG [Spritam] SBDC · 1736049
Levetiracetam Tablet for Oral Suspension [Spritam] SBDF · 1869556
Spritam Oral Liquid Product SBDG · 1869557
Spritam Oral Product SBDG · 1736042
Spritam BN · 1736038

📦 FDA Products & Package NDCs

6 products · 9 package NDCs

9 package NDCs map to RxCUI 1736048 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
43485-0101-03	6 BLISTER PACK in 1 CARTON (43485-101-03) / 1 TABLET, FOR S...	Spritam	Aprecia Pharmaceuticals, LLC	2026-01-31
43485-0101-60	60 BLISTER PACK in 1 CARTON (43485-101-60) / 1 TABLET, FOR...	Spritam	Aprecia Pharmaceuticals, LLC	2016-02-05
43485-0102-03	6 BLISTER PACK in 1 CARTON (43485-102-03) / 1 TABLET, FOR S...	Spritam	Aprecia Pharmaceuticals, LLC	2026-01-31
43485-0102-60	60 BLISTER PACK in 1 CARTON (43485-102-60) / 1 TABLET, FOR...	Spritam	Aprecia Pharmaceuticals, LLC	2016-02-05
43485-0103-60	60 BLISTER PACK in 1 CARTON (43485-103-60) / 1 TABLET, FOR...	Spritam	Aprecia Pharmaceuticals, LLC	2016-02-05
43485-0104-60	60 BLISTER PACK in 1 CARTON (43485-104-60) / 1 TABLET, FOR...	Spritam	Aprecia Pharmaceuticals, LLC	2016-02-05
66993-0100-06	6 BLISTER PACK in 1 CARTON (66993-100-06) / 1 TABLET, FOR S...	Levetiracetam	Prasco Laboratories	2025-01-20
66993-0100-60	60 BLISTER PACK in 1 CARTON (66993-100-60) / 1 TABLET, FOR...	Levetiracetam	Prasco Laboratories	2026-01-16
66993-0101-60	60 BLISTER PACK in 1 CARTON (66993-101-60) / 1 TABLET, FOR...	Levetiracetam	Prasco Laboratories	2026-01-16

Observed labelers: Aprecia Pharmaceuticals, LLC (6) · Prasco Laboratories (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.